Outcomes of hepatic artery infusion therapy for hepatic metastases from colorectal carcinoma after radiological placement of infusion catheters

European Journal of Surgical Oncology

Volumn 33, Issue 6, 2007, Pages 741-745

  Sameshima, S ^a   Horikoshi, H ^a   Motegi, K ^a   Tomozawa, S ^a   Hirayama, I ^a   Saito, T ^a   Sawada, T ^a  

^a GUNMA PREFECTURAL CANCER CENTER   (Japan)

Author keywords

Arteriography; CEA; Distal fixation method; Infusion port; Lymph node metastases; Median survival time; Response rate; Toxicity

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

AGED; ARTERY CATHETERIZATION; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL SURGERY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; LIVER PERFUSION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; ANGIOGRAPHY; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSION PUMPS; LIVER NEOPLASMS; MALE; RADIOGRAPHY, INTERVENTIONAL; RECTAL NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34447096650     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.02.012     Document Type: Article

References (24)

1. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116 4 (1994 Oct) 703-710 (discussion 10-1)
2. Scheele J., Stang R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 1 (1995 Jan-Feb) 59-71
3. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18 16 (2000 Aug) 2938-2947
4. Goldberg R.M., Sargent D.J., Morton R.F., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22 1 (2004 Jan 1) 23-30
5. Colucci G., Gebbia V., Paoletti G., et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23 22 (2005 Aug 1) 4866-4875
6. Martin Jr. J.K., O'Connell M.J., Wieand H.S., et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125 8 (1990 Aug) 1022-1027
7. Kelly R.J., Kemeny N.E., and Leonard G.D. Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer. Clin Colorectal Cancer 5 3 (2005 Sep) 166-174
8. Pinedo H.M., and Peters G.F. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6 10 (1988 Oct) 1653-1664
9. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88 5 (1996 Mar 6) 252-258
10. Tanaka T., Arai Y., Inaba Y., et al. Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 14 1 (2003 Jan) 63-68
11. Seki H., Kimura M., Kamura T., Miura T., Yoshimura N., and Sakai K. Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: value of CT arteriography using an implantable port system. J Comput Assist Tomogr 20 3 (1996 May-Jun) 343-348
12. Goldberg J.A., Kerr D.J., Watson D.G., et al. The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastases. Br J Cancer 61 6 (1990 Jun) 913-915
13. Institute NC. National Cancer Institute Common Toxicity Criteria, version 2.0; 1999.
14. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 3 (2000 Feb 2) 205-216
15. Kerr D.J., McArdle C.S., Ledermann J., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361 9355 (2003 Feb 1) 368-373
16. Kemeny N.E., Niedzwiecki D., Hollis D.R., et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24 9 (2006 Mar 20) 1395-1403
17. Hohn D.C., Stagg R.J., Price D.C., and Lewis B.J. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2′-deoxyuridine. J Clin Oncol 3 9 (1985 Sep) 1257-1260
18. Sofocleous C.T., Schubert J., Kemeny N., et al. Arterial embolization for salvage of hepatic artery infusion pumps. J Vasc Interv Radiol 17 5 (2006 May) 801-806
19. Salonga D., Danenberg K.D., Johnson M., et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6 4 (2000 Apr) 1322-1327
20. Inoue T., Hibi K., Nakayama G., et al. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer. J Gastroenterol 40 2 (2005 Feb) 143-147
21. Kern W., Beckert B., Lang N., et al. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 12 5 (2001 May) 599-603
22. Pohlen U., Mansmann U., Berger G., et al. Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastases. Anticancer Res 24 5B (2004 Sep-Oct) 3275-3282
23. Link K.H., Leder G., Pillasch J., et al. In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Semin Surg Oncol 14 3 (1998 Apr-May) 189-201
24. Allen-Mersh T.G., Glover C., Fordy C., Mathur P., and Quinn H. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. Eur J Surg Oncol 26 5 (2000 Aug) 468-473